Evidence map›Paper›PMID 36675234›Full record

ArticleInternational journal of molecular sciences2023

Establishment of Mucoepidermoid Carcinoma Cell Lines from Surgical and Recurrence Biopsy Specimens.

Shunpei Yamanaka, Susumu Suzuki, Hideaki Ito, Karnan Sivasundaram, Ichiro Hanamura, Ikuko Okubo, Kazuhiro Yoshikawa, Shoya Ono, Taishi Takahara, Akira Satou and 4 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Shunpei YamanakaDepartment of Otorhinolaryngology, Aichi Medical University School of Medicine, Nagakute 480-1195, Japan.
Susumu SuzukiResearch Creation Support Center, Aichi Medical University, Nagakute 480-1195, Japan.ORCID 0000-0002-1466-8824
Hideaki ItoDepartment of Pathology, Aichi Medical University School of Medicine, Nagakute 480-1195, Japan.
Karnan SivasundaramDepartment of Biochemistry, Aichi Medical University, Nagakute 480-1195, Japan.
Ichiro HanamuraDivision of Hematology, Department of Internal Medicine, Aichi Medical University, Nagakute 480-1195, Japan.ORCID 0000-0002-6681-8927
Ikuko OkuboResearch Creation Support Center, Aichi Medical University, Nagakute 480-1195, Japan.
Kazuhiro YoshikawaResearch Creation Support Center, Aichi Medical University, Nagakute 480-1195, Japan.
Shoya OnoDepartment of Maxillofacial Surgery, Aichi Gakuin University School of Dentistry, Nagoya 464-8651, Japan.
Taishi TakaharaDepartment of Surgical Pathology, Aichi Medical University Hospital, Nagakute 480-1195, Japan.
Akira SatouDepartment of Surgical Pathology, Aichi Medical University Hospital, Nagakute 480-1195, Japan.
Toyonori TsuzukiDepartment of Surgical Pathology, Aichi Medical University Hospital, Nagakute 480-1195, Japan.ORCID 0000-0002-4855-4366
Ryuzo UedaDepartment of Tumor Immunology, Aichi Medical University School of Medicine, Nagakute 480-1195, Japan.
Tetsuya OgawaDepartment of Otorhinolaryngology, Aichi Medical University School of Medicine, Nagakute 480-1195, Japan.ORCID 0000-0003-4093-9533
Yasushi FujimotoDepartment of Otorhinolaryngology, Aichi Medical University School of Medicine, Nagakute 480-1195, Japan.
Aichi Medical University · JPAichi Medical University Hospital · JPAichi Gakuin University · JP

Funding

Grants-in-Aid for Scientific Research C from the Ministry of Educa-tion, Japan No. 21K09664 and 21K07203
6 · The paper itself

Abstract

Patients with advanced/recurrent mucoepidermoid carcinoma (MEC) have a poor prognosis. This study aimed to establish and characterize human mucoepidermoid carcinoma cell lines from the initial surgical specimen and biopsy specimen upon recurrence from the same patient to provide a resource for MEC research. MEC specimens from the initial surgical procedure and biopsy upon recurrence were used to establish cell lines. The established cell lines were cytogenetically characterized using multi-color fluorescence in situ hybridization and detection, and the sequence of the

Indexed as

Carcinoma, MucoepidermoidSalivary Gland NeoplasmsBiopsyCell Line, TumorCisplatinDNA-Binding ProteinsFluorouracilHumansIn Situ Hybridization, FluorescenceOncogene Proteins, FusionTrans-ActivatorsTranscription FactorsCisplatinDNA-Binding ProteinsFluorouracilOncogene Proteins, FusionTrans-ActivatorsTranscription Factors5-fluorouracilcetuximabchimeric genecisplatinEGFRhead and neck mucoepidermoid carcinomakaryotypeMulti-color FISH

Identifiers

PMID36675234
PMCPMC9865506
OpenAlexW4316664720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.